SEC 13F Intelligence

Managers / Q2 2022 · view latest →

AKO CAPITAL LLP

CIK 0001376879 · 2ND FLOOR, 1 NEWMAN ST, LONDON, X0, WIT 1PB · 44(0) 207-070-2400

Reported Value
$7.1B
Q2 2022
Positions
25
Filings on Record
29
2019–present window
Filed
Aug 9, 2022
original filing

Summary

Ako Capital LLP reported $7.1B in U.S.-listed holdings across 25 positions for Q2 2022.

Its largest position, TMO, represents 9.2% of the portfolio.

The book was largely unchanged from Q1 2022.

Portfolio Metrics

Turnover
+4.6%
vs prior filed quarter
Top-10 Concentration
+62.4%
share of reported value
Largest Position
+9.2%
Thermo Fisher Scientific

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q1 ’19: $3.3BQ1 ’19Q2 ’19: $3.9BQ3 ’19: $4.1BQ4 ’19: $4.6BQ1 ’20: $4.7BQ1 ’20Q2 ’20: $5.7BQ3 ’20: $6.4BQ4 ’20: $7.8BQ1 ’21: $8.1BQ1 ’21Q2 ’21: $8.9BQ3 ’21: $9.6BQ4 ’21: $10.3BQ1 ’22: $9.3BQ1 ’22Q2 ’22: $7.1BQ3 ’22: $6.1BQ4 ’22: $6.2BQ1 ’23: $6.6BQ1 ’23Q2 ’23: $6.6BQ3 ’23: $6.1BQ4 ’23: $7.0BQ1 ’24: $7.1BQ1 ’24Q2 ’24: $7.3BQ3 ’24: $7.7BQ4 ’24: $7.2BQ1 ’25: $7.7BQ1 ’25Q2 ’25: $7.9BQ3 ’25: $7.0BQ4 ’25: $6.6BQ1 ’26: $5.1BQ1 ’26filingsflow.com

Portfolio Composition

By security type
Common Stock: 91.5%Other: 4.3%ADR: 4.2%
  • Common Stock · 91.5% · $6.5B
  • Other · 4.3% · $308M
  • ADR · 4.2% · $297M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2022 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
VVISA INCADDED+1.11M2.42M+$186M$477M
GOOGALPHABET INCTRIMMED−131.7K44.9K−$395M$98M
EBAYEBAY INCTRIMMED−2.66M2.14M−$186M$89M
MCOMOODYS CORPTRIMMED−367.1K298.4K−$143M$81M
DGDOLLAR GEN CORP NEWADDED+438.4K1.30M+$127M$319M
LINDE PLCTRIMMED−921.4K1.07M−$332M$308M
PGPROCTER AND GAMBLE COTRIMMED−759.4K1.20M−$127M$173M
ALLEALLEGION PLCADDED+676.6K2.47M+$45M$242M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2022

25 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1TMOTHERMO FISHER SCIENTIFIC INChistory →COM9.23%$659M1.21M
2ACNACCENTURE PLC IRELANDhistory →SHS CLASS A8.91%$636M2.29M
3BKNGBOOKING HLDGS INChistory →COM8.46%$604M345.3K
4VVISA INChistory →COM CL A6.68%$477M2.42M
5EFXEQUIFAX INChistory →COM5.69%$406M2.22M
6ICEINTERCONTINENTAL EXCHANGE INChistory →COM5.42%$387M4.12M
7ELLAUDER ESTEE COS INChistory →CL A4.63%$331M1.30M
8ALCALCON INChistory →ORD SHS4.59%$328M4.69M
9DGDOLLAR GEN CORP NEWhistory →COM4.47%$319M1.30M
10LINDE PLCCOM4.31%$308M1.07M
11DEODIAGEO PLChistory →SPON ADR NEW4.16%$297M1.71M
12ADBEADOBE INChistory →COM3.92%$280M764.6K
13ZTSZOETIS INChistory →CL A3.52%$251M1.46M
14OTISOTIS WORLDWIDE CORPhistory →COM3.46%$247M3.50M
15ALLEALLEGION PLChistory →ORD SHS3.39%$242M2.47M
16FICOFAIR ISAAC CORPhistory →COM2.76%$197M490.9K
17NKENIKE INChistory →CL B2.74%$196M1.91M
18RACEFERRARI N Vhistory →COM2.45%$175M954.9K
19PGPROCTER AND GAMBLE COhistory →COM2.42%$173M1.20M
20AKXANSYS INChistory →COM2.05%$147M612.7K
21CHTRCHARTER COMMUNICATIONS INC Nhistory →CL A1.67%$120M255.2K
22GOOGALPHABET INChistory →CAP STK CL C1.37%$98M44.9K
23MARMARRIOTT INTL INC NEWhistory →CL A1.30%$93M682.8K
24EBAYEBAY INChistory →COM1.25%$89M2.14M
25MCOMOODYS CORPhistory →COM1.14%$81M298.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$5.1B27May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$6.6B22Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$7.0B23Nov 13, 202513F-HRchanges · EDGAR ↗
Q2 2025$7.9B25Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$7.7B26May 14, 202513F-HRchanges · EDGAR ↗
Q4 2024$7.2B27Feb 12, 202513F-HRchanges · EDGAR ↗
Q3 2024$7.7B25Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$7.3B26Aug 13, 202413F-HRchanges · EDGAR ↗
Q1 2024$7.1B27May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$7.0B29Feb 15, 202413F-HRchanges · EDGAR ↗
Q3 2023$6.1B27Nov 6, 202313F-HRchanges · EDGAR ↗
Q2 2023$6.6B24Aug 1, 202313F-HRchanges · EDGAR ↗
Q1 2023$6.6B24Apr 25, 202313F-HRchanges · EDGAR ↗
Q4 2022$6.2B23Jan 18, 202313F-HRchanges · EDGAR ↗
Q3 2022$6.1B24Nov 1, 202213F-HRchanges · EDGAR ↗
Q2 2022$7.1B25Aug 9, 202213F-HRchanges · EDGAR ↗
Q1 2022$9.3B25May 4, 202213F-HRchanges · EDGAR ↗
Q4 2021$10.3B24Feb 4, 202213F-HRchanges · EDGAR ↗
Q3 2021$9.6B25Nov 3, 202113F-HRchanges · EDGAR ↗
Q2 2021$8.9B26Aug 6, 202113F-HRchanges · EDGAR ↗
Q1 2021$8.1B27May 6, 202113F-HRchanges · EDGAR ↗
Q4 2020$7.8B26Feb 2, 202113F-HRchanges · EDGAR ↗
Q3 2020$6.4B25Nov 2, 202013F-HRchanges · EDGAR ↗
Q2 2020$5.7B24Aug 3, 202013F-HRchanges · EDGAR ↗
Q1 2020$4.7B25May 6, 202013F-HRchanges · EDGAR ↗
Q4 2019$4.6B21Feb 13, 202013F-HRchanges · EDGAR ↗
Q3 2019$4.1B21Nov 6, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.9B21Aug 5, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.3B19May 8, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.